“Neuregulin-4 (Nrg-4) As a Metabolic Regulator: A Comprehensive Review of Its Association With Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus”. Vascular and Endovascular Review 8, no. 19s (December 10, 2025): 177–181. Accessed January 15, 2026. https://verjournal.com/index.php/ver/article/view/1430.